MAXIMIZING ONCOLOGY ANALYSIS WITH INTEGRATED KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

during the rapidly evolving discipline of oncology exploration, correct and productive mutation screening is crucial for building focused therapies. The KRAS companies System plays a pivotal job With this landscape by presenting complete solutions for KRAS mutation profiling and Evaluation. KRAS mutations, present in around 95% of RAS-related oncog